Three-Weekly Docetaxel (T) Plus Capecitabine (X) In 1st And 2nd Line Metastatic Esophageal Cancer (Mec): Final Results Of The Phase Ii Dacapo Trial.
JOURNAL OF CLINICAL ONCOLOGY(2005)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2005)